Literature DB >> 15256873

Effectiveness and Safety of the PEGT/PBT Copolymer Scaffold as Dermal Substitute in Scar Reconstruction Wounds (Feasibility Trial).

I Mensik1, E N Lamme, J Riesle, P Brychta.   

Abstract

Skin defects left after excision of hypertrophic scars were treated with a dermal substitute and split-thickness skin grafts transplanted after vascularisation of the substitute. The used substitute was a synthetic porous scaffold made from the biodegradable copolymer polyethyleneglycol-terephtalate and polybuthylene-terephtalate. The study was designed to assess the rate of granulation tissue formation, graft take, and after 3 and 12 months the quality of life (pain, comfort of treatment, cosmetic or functional nuisance), scar formation and wound contraction. In addition, scaffold biodegradation and scar tissue formation were evaluated histologically.Seven patients with different causes of burn injury were enrolled, of which 5 completed the study. In the first 4 patients the time between scaffold application and split-thickness skin overgrafting was in between 17 and 24 days. The time point of overgrafting was significantly reduced to 10-12 days by meshing of the dermal scaffold as evidenced in the last 3 patients. Histological evaluation at 3 months revealed normal generation of dermal tissue, however, the collagen bundles were parallel organized like in scar tissue. In the deeper layers of the neodermis, fragments of the dermal substitute were present, causing a mild inflammatory response. One year post-treatment, some fragments of the copolymer were still observed. The extent of wound contraction after successful overgrafting ranged from 30% to 57% after 1 year. All 5 patients showed an improvement in the total Vancouver Scar Score compared to the value before scar removal being similar to what can be expected when treated with split-thickness skin grafts alone. No unanticipated adverse effects due to application of the substitute were observed.We conclude that although this synthetic dermal substitute can be safely used in humans, the presence of 3D dermal template in a full-thickness skin defect will not automatically improve the skin tissue regeneration process or inhibit wound contraction.

Entities:  

Year:  2002        PMID: 15256873     DOI: 10.1023/A:1024674325253

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  6 in total

1.  Biodegradable PEG-Based Amphiphilic Block Copolymers for Tissue Engineering Applications.

Authors:  Artem B Kutikov; Jie Song
Journal:  ACS Biomater Sci Eng       Date:  2015-05-26

2.  Label-free Raman monitoring of extracellular matrix formation in three-dimensional polymeric scaffolds.

Authors:  Aliz Kunstar; Anne M Leferink; Paul I Okagbare; Michael D Morris; Blake J Roessler; Cees Otto; Marcel Karperien; Clemens A van Blitterswijk; Lorenzo Moroni; Aart A van Apeldoorn
Journal:  J R Soc Interface       Date:  2013-07-03       Impact factor: 4.118

3.  Surface Treatment of PEOT/PBT (55/45) with a Dielectric Barrier Discharge in Air, Helium, Argon and Nitrogen at Medium Pressure.

Authors:  Pieter Cools; Mahtab Asadian; Wannes Nicolaus; Heidi Declercq; Rino Morent; Nathalie De Geyter
Journal:  Materials (Basel)       Date:  2018-03-07       Impact factor: 3.623

4.  Microwell scaffolds for the extrahepatic transplantation of islets of Langerhans.

Authors:  Mijke Buitinga; Roman Truckenmüller; Marten A Engelse; Lorenzo Moroni; Hetty W M Ten Hoopen; Clemens A van Blitterswijk; Eelco Jp de Koning; Aart A van Apeldoorn; Marcel Karperien
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

5.  Regenerating articular tissue by converging technologies.

Authors:  Lorenzo Moroni; Doreen Hamann; Luca Paoluzzi; Jeroen Pieper; Joost R de Wijn; Clemens A van Blitterswijk
Journal:  PLoS One       Date:  2008-08-21       Impact factor: 3.240

6.  In vitro degradation profiles and in vivo biomaterial-tissue interactions of microwell array delivery devices.

Authors:  Elahe Hadavi; Rick H W de Vries; Alexandra M Smink; Bart de Haan; Jeroen Leijten; Leendert W Schwab; Marcel H B J Karperien; Paul de Vos; Pieter J Dijkstra; Aart A van Apeldoorn
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2020-07-16       Impact factor: 3.368

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.